Although current treatments for localized ovarian cancer are highly effective, this cancer still remains the most lethal gynecological malignancy, largely owing to the fact that it is often detected only after tumor cells leave the primary tumor. Clinicians have long noted a clear predilection for ovarian cancer to metastasize to the soft omentum. Here, we show that this tropism is due not only to chemical signals but also mechanical cues. Metastatic ovarian cancer cells (OCCs) preferentially adhere to soft microenvironments and display an enhanced malignant phenotype, including increased migration, proliferation and chemoresistance. To understand the cell–matrix interactions that are used to sense the substrate rigidity, we utilized traction force microscopy (TFM) and found that, on soft substrates, human OCCs increased both the magnitude of traction forces as well as their degree of polarization. After culture on soft substrates, cells underwent morphological elongation characteristic of epithelial-to-mesenchymal transition (EMT), which was confirmed by molecular analysis. Consistent with the idea that mechanical cues are a key determinant in the spread of ovarian cancer, the observed mechanosensitivity was greatly decreased in less-metastatic OCCs. Finally, we demonstrate that this mechanical tropism is governed through a Rho–ROCK signaling pathway.

Author contributions

The study was conceived and designed by D.J.M. and M.R.D. Both D.J.M. and Q.M.N.K. generated data. D.J.M. developed the methodologies and analyzed and interpreted data. The manuscript was written by D.J.M. and M.R.D.

Funding

Funding for this work was provided by the National Science Foundation [grant number 1032527]; and the Georgia Tech and Emory Center for Regenerative Medicine [grant number NSF 1411304]. Some of the materials used in this work were provided by the Texas A and M Health Science Center College of Medicine Institute for Regenerative Medicine at Scott & White, through a grant from the National Center for Research Resources of the National Institutes of Health [grant number P40RR017447]. Deposited in PMC for release after 12 months.

You do not currently have access to this content.